What is the target serum transferrin‑iron saturation (TSAT) range during pregnancy?

Target Iron Saturation for Pregnancy

There is no established target transferrin saturation (TSAT) range specifically for pregnancy in current guidelines. The available evidence focuses on hemoglobin/hematocrit screening and iron supplementation dosing rather than TSAT targets.

Key Clinical Approach

What Guidelines Actually Recommend

The USPSTF guidelines 1 focus on:

• Screening method: Hemoglobin or hematocrit levels as the first-line test
• Treatment dosing: 60-120 mg elemental iron daily for iron deficiency anemia
• Supplementation: 30 mg elemental iron daily in early pregnancy, with 60-100 mg daily for high-risk populations

Notably, these guidelines do not specify TSAT targets for pregnant women.

Why TSAT Isn't Emphasized in Pregnancy

The evidence reveals an important gap: while TSAT is mentioned as a diagnostic tool in some contexts, pregnancy guidelines have not established specific TSAT thresholds. This differs from other conditions:

• Non-pregnancy iron deficiency: TSAT <20% is commonly used as a diagnostic cutoff 2
• Chronic kidney disease: TSAT targets of 20-50% are specified 2
• Heart failure: TSAT <20% defines functional iron deficiency 3

Practical Clinical Management

In the absence of pregnancy-specific TSAT targets, focus on:

1. Screen with hemoglobin/hematocrit as the primary method 1
2. If iron deficiency anemia is diagnosed, treat with 60-120 mg elemental iron daily 1
3. For prevention, use 30 mg elemental iron daily in standard-risk pregnancies 1
4. Monitor response through hemoglobin levels rather than TSAT

Important Caveats

• The lack of TSAT targets in pregnancy guidelines reflects insufficient evidence linking specific TSAT values to maternal/fetal outcomes 1
• Hemoglobin and hematocrit remain the standard screening and monitoring parameters
• If you need to use TSAT diagnostically (e.g., distinguishing iron deficiency from other causes of anemia), the general threshold of <20% suggests iron deficiency 2, but this is extrapolated from non-pregnancy populations

The evidence base for TSAT monitoring in pregnancy is inadequate, and current practice appropriately relies on hemoglobin-based assessment and empiric iron supplementation dosing.